Overall, this finding would suggest that the effect of WMHs is rather similar across diagnoses, but their load, regional placement and interplay with alpha-synuclein and Alzheimer’s disease-related pathological changes may differ. This evidence concerns the gene SNCA and early-onset autosomal dominant Alzheimer disease.